Literature DB >> 23295857

Fast motor axon loss in SMARD1 does not correspond to morphological and functional alterations of the NMJ.

Frank Krieger1, Nicole Elflein, Rocio Ruiz, Joana Guerra, Antonio L Serrano, Esther Asan, Lucia Tabares, Sibylle Jablonka.   

Abstract

Spinal muscular atrophy with respiratory distress type 1 (SMARD1) is a childhood motoneuron disease caused by mutations in the gene encoding for IGHMBP2, an ATPase/Helicase. Paralysis of the diaphragm is an early and prominent clinical sign resulting both from denervation and myopathy. In skeletal muscles, muscle atrophy mainly results from loss of motoneuron cell bodies and axonal degeneration. Although it is well known that loss of motoneurons at the lumbar spinal cord is an early event in the pathogenesis of the disease, it is not clear whether the corresponding proximal axons and NMJs are also early affected. In order to address this question, we have investigated the time course of the disease progression at the level of the motoneuron cell body, proximal axon (ventral root), distal axon (sciatic nerve), NMJ, and muscle fiber in Nmd(2J) mice, a mouse model for SMARD1. Our results show an early and apparently parallel loss of motoneurons, proximal axons, and NMJs. In affected muscles, however, denervated fibers coexist with NMJs with normal morphology and unaltered neurotransmission. Furthermore, unaffected axons are able to sprout and reinnervate muscle fibers, suggesting selective vulnerability of neurons to Ighmbp2 deficiency. The preservation of the NMJ morphology and neurotransmission in the Nmd(2J) mouse until motor axon loss takes place, differs from that observed in SMA mouse models in which NMJ impairment is an early and more general phenomenon in affected muscles.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23295857     DOI: 10.1016/j.nbd.2012.12.010

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  12 in total

1.  Selective vulnerability in neuronal populations in nmd/SMARD1 mice.

Authors:  Eric Villalón; Monir Shababi; Rachel Kline; Zachary C Lorson; Kyra M Florea; Christian L Lorson
Journal:  Hum Mol Genet       Date:  2018-02-15       Impact factor: 6.150

2.  Muscle fiber-type selective propensity to pathology in the nmd mouse model of SMARD1.

Authors:  Eric Villalón; Naomi N Lee; Jose Marquez; Christian L Lorson
Journal:  Biochem Biophys Res Commun       Date:  2019-06-28       Impact factor: 3.575

3.  Genetic determinants of fibro-osseous lesions in aged inbred mice.

Authors:  Annerose Berndt; Cheryl Ackert-Bicknell; Kathleen A Silva; Victoria E Kennedy; Beth A Sundberg; Justin M Cates; Paul N Schofield; John P Sundberg
Journal:  Exp Mol Pathol       Date:  2015-11-14       Impact factor: 3.362

4.  Truncating and missense mutations in IGHMBP2 cause Charcot-Marie Tooth disease type 2.

Authors:  Ellen Cottenie; Andrzej Kochanski; Albena Jordanova; Boglarka Bansagi; Magdalena Zimon; Alejandro Horga; Zane Jaunmuktane; Paola Saveri; Vedrana Milic Rasic; Jonathan Baets; Marina Bartsakoulia; Rafal Ploski; Pawel Teterycz; Milos Nikolic; Ros Quinlivan; Matilde Laura; Mary G Sweeney; Franco Taroni; Michael P Lunn; Isabella Moroni; Michael Gonzalez; Michael G Hanna; Conceicao Bettencourt; Elodie Chabrol; Andre Franke; Katja von Au; Markus Schilhabel; Dagmara Kabzińska; Irena Hausmanowa-Petrusewicz; Sebastian Brandner; Siew Choo Lim; Haiwei Song; Byung-Ok Choi; Rita Horvath; Ki-Wha Chung; Stephan Zuchner; Davide Pareyson; Matthew Harms; Mary M Reilly; Henry Houlden
Journal:  Am J Hum Genet       Date:  2014-10-30       Impact factor: 11.025

Review 5.  Clinical and molecular features and therapeutic perspectives of spinal muscular atrophy with respiratory distress type 1.

Authors:  Fiammetta Vanoli; Paola Rinchetti; Francesca Porro; Valeria Parente; Stefania Corti
Journal:  J Cell Mol Med       Date:  2015-06-20       Impact factor: 5.310

6.  Lack of GDAP1 induces neuronal calcium and mitochondrial defects in a knockout mouse model of charcot-marie-tooth neuropathy.

Authors:  Manuela Barneo-Muñoz; Paula Juárez; Azahara Civera-Tregón; Laura Yndriago; David Pla-Martin; Jennifer Zenker; Carmen Cuevas-Martín; Anna Estela; María Sánchez-Aragó; Jerónimo Forteza-Vila; José M Cuezva; Roman Chrast; Francesc Palau
Journal:  PLoS Genet       Date:  2015-04-10       Impact factor: 5.917

7.  Morphological and functional remodelling of the neuromuscular junction by skeletal muscle PGC-1α.

Authors:  Anne-Sophie Arnold; Jonathan Gill; Martine Christe; Rocío Ruiz; Shawn McGuirk; Julie St-Pierre; Lucía Tabares; Christoph Handschin
Journal:  Nat Commun       Date:  2014-04-01       Impact factor: 14.919

8.  Differentiation defects in primary motoneurons from a SMARD1 mouse model that are insensitive to treatment with low dose PEGylated IGF1.

Authors:  Frank Krieger; Friedrich Metzger; Sibylle Jablonka
Journal:  Rare Dis       Date:  2014-06-10

9.  Transcriptional analysis of apoptotic cerebellar granule neurons following rescue by gastric inhibitory polypeptide.

Authors:  Barbara Maino; Maria Teresa Ciotti; Pietro Calissano; Sebastiano Cavallaro
Journal:  Int J Mol Sci       Date:  2014-04-01       Impact factor: 5.923

10.  Sarm1 Deletion, but Not WldS, Confers Lifelong Rescue in a Mouse Model of Severe Axonopathy.

Authors:  Jonathan Gilley; Richard R Ribchester; Michael P Coleman
Journal:  Cell Rep       Date:  2017-10-03       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.